MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) shares traded up 17.9% during mid-day trading on Thursday . The company traded as high as $1.53 and last traded at $1.45. 640,780 shares changed hands during trading, an increase of 378% from the average session volume of 134,123 shares. The stock had previously closed at $1.23.
MyMD Pharmaceuticals Stock Performance
The business’s 50-day moving average price is $1.40 and its 200 day moving average price is $1.64.
About MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
Featured Articles
- Five stocks we like better than MyMD Pharmaceuticals
- 3 Fintech Stocks With Good 2021 Prospects
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- Consumer Discretionary Stocks Explained
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- 3 Stocks to Consider Buying in October
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
